Rolf Thieringer

4.6k total citations
39 papers, 2.5k citations indexed

About

Rolf Thieringer is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Rolf Thieringer has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Cell Biology. Recurrent topics in Rolf Thieringer's work include Hormonal Regulation and Hypertension (17 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Aldose Reductase and Taurine (8 papers). Rolf Thieringer is often cited by papers focused on Hormonal Regulation and Hypertension (17 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Aldose Reductase and Taurine (8 papers). Rolf Thieringer collaborates with scholars based in United States, Canada and Germany. Rolf Thieringer's co-authors include Samuel D. Wright, Anne Hermanowski‐Vosatka, Russell L. Delude, Matthew J. Fenton, Patricia A. Detmers, Joel P. Berger, Steven S. Mundt, W H Kunau, David E. Moller and Birming Wong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Rolf Thieringer

39 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rolf Thieringer United States	27	1.0k	738	705	341	288	39	2.5k
Hans Hansen Denmark	29	1.4k 1.4×	257 0.3×	322 0.5×	93 0.3×	266 0.9×	47	2.5k
Jeffrey L. Nordstrom United States	29	1.9k 1.8×	489 0.7×	209 0.3×	93 0.3×	186 0.6×	63	3.6k
Shuping Zhao China	28	1.3k 1.3×	419 0.6×	138 0.2×	138 0.4×	234 0.8×	68	2.9k
Lindy L. Thomsen New Zealand	23	889 0.9×	1.5k 2.0×	123 0.2×	149 0.4×	643 2.2×	47	3.4k
Ganesh M. Sathe United States	28	1.9k 1.8×	614 0.8×	90 0.1×	197 0.6×	359 1.2×	56	3.3k
William J. McKinstry Australia	26	1.3k 1.3×	665 0.9×	178 0.3×	145 0.4×	832 2.9×	54	3.0k
Simon J.T. Mao Taiwan	27	903 0.9×	204 0.3×	615 0.9×	88 0.3×	285 1.0×	88	2.8k
Sylvie Marleau Canada	20	557 0.5×	736 1.0×	96 0.1×	160 0.5×	725 2.5×	65	2.2k
Kurt E. Amrein Switzerland	25	1.4k 1.3×	1.0k 1.4×	249 0.4×	61 0.2×	201 0.7×	39	2.8k
Sherrie Tafuri United States	23	2.5k 2.4×	223 0.3×	190 0.3×	119 0.3×	684 2.4×	27	3.3k

Countries citing papers authored by Rolf Thieringer

Since Specialization

Citations

This map shows the geographic impact of Rolf Thieringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Thieringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Thieringer more than expected).

Fields of papers citing papers by Rolf Thieringer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Thieringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Thieringer. The network helps show where Rolf Thieringer may publish in the future.

Co-authorship network of co-authors of Rolf Thieringer

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Thieringer. A scholar is included among the top collaborators of Rolf Thieringer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Thieringer. Rolf Thieringer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maletic, Milana, Michael J. Szymonifka, Steven S. Mundt, et al.. (2011). Bicyclo[2.2.2]octyltriazole inhibitors of 11β-hydoxysteroid dehydrogenase type 1. Pharmacological agents for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters. 21(8). 2568–2572. 12 indexed citations

Berthiaume, Magalie, Mathieu Laplante, William T. Festuccia, et al.. (2009). Preliminary report: pharmacologic 11β-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet. Metabolism. 59(1). 114–117. 15 indexed citations

Berthiaume, Magalie, Mathieu Laplante, William T. Festuccia, et al.. (2009). Additive action of 11β-HSD1 inhibition and PPAR-γ agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats. International Journal of Obesity. 33(5). 601–604. 16 indexed citations

Olson, Steven H., Donald W. Graham, Gool F. Patel, et al.. (2008). Phenylcyclobutyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 18(11). 3412–3416. 38 indexed citations

Berthiaume, Magalie, Mathieu Laplante, William T. Festuccia, et al.. (2007). 11β-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. American Journal of Physiology-Endocrinology and Metabolism. 293(4). E1045–E1052. 48 indexed citations

Mundt, Steven S., Kelli Solly, Rolf Thieringer, & Anne Hermanowski‐Vosatka. (2005). Development and Application of a Scintillation Proximity Assay (SPA) for Identification of Selective Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1. Assay and Drug Development Technologies. 3(4). 367–375. 36 indexed citations

Gu, Xin, Jasminka Dragovic, Gloria C. Koo, et al.. (2005). Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11β-HSD1: Novel therapeutic agents for the treatment of metabolic syndrome. Bioorganic & Medicinal Chemistry Letters. 15(23). 5266–5269. 40 indexed citations

Olson, Steven H., Susan D. Aster, Kai Brown, et al.. (2005). Adamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1. Bioorganic & Medicinal Chemistry Letters. 15(19). 4359–4362. 76 indexed citations

Thieringer, Rolf, James M. Balkovec, Steven S. Mundt, et al.. (2004). A novel non-steroidal inhibitor of 11beta-hydroxysteroid dehydrogenase type 1 improves features of metabolic syndrome in murine disease models. 7. 6 indexed citations

10.

Thieringer, Rolf, et al.. (2001). 11β-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages. The Journal of Immunology. 167(1). 30–35. 146 indexed citations

11.

Cai, Tian‐Quan, Birming Wong, Steven S. Mundt, et al.. (2001). Induction of 11β-hydroxysteroid dehydrogenase type 1 but not -2 in human aortic smooth muscle cells by inflammatory stimuli. The Journal of Steroid Biochemistry and Molecular Biology. 77(2-3). 117–122. 85 indexed citations

12.

Berger, Joel P., Michael Tanen, Alex Elbrecht, et al.. (2001). Peroxisome Proliferator-activated Receptor-γ Ligands Inhibit Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Activity. Journal of Biological Chemistry. 276(16). 12629–12635. 175 indexed citations

13.

Thieringer, Rolf, Judy Fenyk‐Melody, Patricia A. Detmers, et al.. (2000). Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo. The Journal of Immunology. 164(2). 1046–1054. 170 indexed citations

14.

Detmers, P A, et al.. (1998). Role of stress-activated mitogen-activated protein kinase (p38) in beta 2-integrin-dependent neutrophil adhesion and the adhesion-dependent oxidative burst.. PubMed. 161(4). 1921–9. 106 indexed citations

15.

Thiéblemont, Nathalie, Rolf Thieringer, & Samuel D. Wright. (1998). Innate Immune Recognition of Bacterial Lipopolysaccharide: Dependence on Interactions with Membrane Lipids and Endocytic Movement. Immunity. 8(6). 771–777. 69 indexed citations

16.

Wooten, R. Mark, Tom Morrison, John H. Weis, et al.. (1998). The Role of CD14 in Signaling Mediated by Outer Membrane Lipoproteins of Borrelia burgdorferi. The Journal of Immunology. 160(11). 5485–5492. 126 indexed citations

17.

Thieringer, Rolf, et al.. (1994). CD14-dependent induction of protein tyrosine phosphorylation by lipopolysaccharide in murine B-lymphoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1223(1). 36–46. 13 indexed citations

18.

Allen, Lee‐Ann H., et al.. (1994). Genetic evidence supporting the role of peroxisome assembly factor (PAF)-1 in peroxisome biogenesis. Polymerase chain reaction detection of a missense mutation in PAF-1 of Chinese hamster ovary cells.. Journal of Biological Chemistry. 269(16). 11734–11742. 2 indexed citations

19.

Heusden, G. Paul H. van, et al.. (1992). Increased cholesterol synthesis in Chinese hamster ovary cells deficient in peroxisomes. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1126(1). 81–87. 22 indexed citations

20.

Lazarow, Paul B., Rolf Thieringer, Gerald Cohen, Tsuneo Imanaka, & Gillian M. Small. (1991). Chapter 14 Protein Import into Peroxisomes in Vitro. Methods in cell biology. 34. 303–326. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact